Company Filing History:
Years Active: 2017-2025
Title: The Innovative Work of Xuhui Huang in Neuroprotection
Introduction
Xuhui Huang, based in Hong Kong, is an accomplished inventor recognized for his contributions to neuroprotective research. With a focus on neurodegenerative disorders such as Alzheimer's Disease, his innovative approaches aim to mitigate neurotoxicity and improve therapeutic outcomes for affected individuals.
Latest Patents
Huang holds a significant patent related to EphA4 inhibitors as neuroprotective agents. This groundbreaking discovery reveals the critical role of EphA4 signaling in neurodegenerative conditions exacerbated by β-amyloid-induced neurotoxicity. The patent outlines new therapeutic methods, agents, and kits designed for treating diseases linked to overactive EphA4 signaling. Furthermore, it provides methodologies for identifying additional compounds that can serve as effective therapeutic agents in these conditions.
Career Highlights
Xuhui Huang is affiliated with The Hong Kong University of Science and Technology, where his research is at the forefront of neurobiology and neuropharmacology. His dedication to advancing scientific knowledge has positioned him as a key player in his field, contributing to innovative solutions for some of the most challenging health issues.
Collaborations
Huang often collaborates with esteemed colleagues, including Nancy Yuk Yu Ip and Kit Yu Fu. Together, they work towards enhancing our understanding of neurodegenerative diseases and developing new therapeutic strategies, thereby making significant strides in medical research.
Conclusion
Xuhui Huang exemplifies the spirit of innovation in the field of neuroprotection. His patent addresses critical issues related to neurodegenerative disorders, showcasing his potential to influence therapeutic practices and improve patient outcomes. With a strong foundation in research and collaboration, Huang continues to impact the scientific community and the lives of many.